Subscribe free

HPB & Spleen ·

Metabolic syndrome increases cholangiocarcinoma risk significantly.

A large-scale population-based cohort study involving 4,932,211 adults revealed that individuals with metabolic syndrome face a significantly heightened risk of cholangiocarcinoma, with a multivariate-adjusted hazard ratio of 1.20. During 35,879,371 person-years of follow-up, there were 6,117 identified cases, with incidence rates rising in correlation with the number of metabolic components. Those with five metabolic factors had a hazard ratio of 1.67. Effective management of metabolic syndrome may lower cholangiocarcinoma occurrence.

Journal Article by Chen TI, Chen MH (…) Lee MH et 11 al. in Hepatology

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Hepatology

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

Surg Endosc6 Nov 2026

A new cut for robotic liver surgery

A close-to-open cutting method was used for robotic liver resection, with no bile leaks and shorter hospital stays than after laparoscopy.

Surg Endosc6 Nov 2026

Robotic bile duct stone surgery: fewer complications

Removing large common bile duct stones with a robot rather than laparoscopically was linked to fewer complications and shorter hospital stays, at a higher cost, in a study from one Chinese hospital.

All papers in HPB & Spleen →